William Blair Brokers Decrease Earnings Estimates for DLB

Dolby Laboratories (NYSE:DLB) – Analysts at William Blair dropped their Q1 2026 earnings per share estimates for Dolby Laboratories in a report released on Wednesday, November 19th. William Blair analyst R. Schackart now anticipates that the electronics maker will post earnings per share of $0.59 for the quarter, down from their prior estimate of $0.96. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.94 per share. William Blair also issued estimates for Dolby Laboratories’ Q2 2026 earnings at $1.12 EPS, Q3 2026 earnings at $0.75 EPS, Q4 2026 earnings at $0.65 EPS and FY2027 earnings at $3.31 EPS.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The business had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. During the same period in the prior year, the company posted $0.61 earnings per share. Dolby Laboratories’s revenue was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS.

DLB has been the subject of several other reports. Robert W. Baird began coverage on Dolby Laboratories in a research note on Friday, September 5th. They issued a “neutral” rating and a $74.00 price target for the company. Tigress Financial upped their target price on Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Baird R W raised Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Rosenblatt Securities decreased their price target on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Wednesday. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Thursday, November 13th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $92.00.

Dolby Laboratories Stock Up 3.1%

NYSE DLB opened at $67.52 on Monday. Dolby Laboratories has a 12-month low of $64.02 and a 12-month high of $89.66. The firm has a 50-day moving average price of $68.59 and a two-hundred day moving average price of $72.34. The company has a market capitalization of $6.47 billion, a P/E ratio of 24.73 and a beta of 0.97.

Institutional Investors Weigh In On Dolby Laboratories

Several hedge funds and other institutional investors have recently made changes to their positions in DLB. Vanguard Group Inc. boosted its stake in shares of Dolby Laboratories by 7.1% during the first quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock valued at $605,194,000 after purchasing an additional 502,110 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of Dolby Laboratories by 7.8% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 15,777 shares of the electronics maker’s stock valued at $1,172,000 after buying an additional 1,146 shares during the period. Fiera Capital Corp raised its holdings in Dolby Laboratories by 19.0% in the 1st quarter. Fiera Capital Corp now owns 639,404 shares of the electronics maker’s stock valued at $51,351,000 after buying an additional 102,028 shares during the last quarter. Comerica Bank raised its holdings in Dolby Laboratories by 83.2% in the 1st quarter. Comerica Bank now owns 105,570 shares of the electronics maker’s stock valued at $8,478,000 after buying an additional 47,936 shares during the last quarter. Finally, Ethic Inc. acquired a new stake in Dolby Laboratories during the 1st quarter worth approximately $536,000. 58.56% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of the business’s stock in a transaction dated Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the completion of the transaction, the chief executive officer owned 114,725 shares of the company’s stock, valued at approximately $7,901,110.75. The trade was a 17.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 38.39% of the company’s stock.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd will be given a $0.36 dividend. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Tuesday, December 2nd. Dolby Laboratories’s dividend payout ratio (DPR) is presently 54.75%.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.